πŸ‡ΊπŸ‡Έ FDA
Patent

US 12024512

Cocrystal

granted A61KA61K31/4545A61P

Quick answer

US patent 12024512 (Cocrystal) held by Takeda Pharmaceutical Company Limited expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4545, A61P, A61P35/00